The AI revolution is creating a massive divide in the tech sector, and the latest earnings reports show exactly where the money is flowing. ServiceNow is proving that it can integrate AI to drive revenue growth and squash disruption fears, while IBM is ac
The AI revolution is creating a massive divide in the tech sector, and the latest earnings reports show exactly where the money is flowing. ServiceNow is proving that it can integrate AI to drive revenue growth and squash disruption fears, while IBM is actively cutting its outlook, signaling it is losing the battle. By betting on ServiceNow to outperform while simultaneously betting against IBM, you capture the shift in enterprise spending toward platforms that are successfully monetizing AI, regardless of whether the overall tech market goes up or down.
Idea
The AI revolution is creating a massive divide in the tech sector, and the latest earnings reports show exactly where the money is flowing. ServiceNow is proving that it can integrate AI to drive revenue growth and squash disruption fears, while IBM is actively cutting its outlook, signaling it is losing the battle. By betting on ServiceNow to outperform while simultaneously betting against IBM, you capture the shift in enterprise spending toward platforms that are successfully monetizing AI, regardless of whether the overall tech market goes up or down.
Advanced Analysis — institutional-depth research report
Verdict: compelling thesis, premature trigger
The fundamental divergence between ServiceNow (20.9% revenue growth, 77.5% gross margin) and IBM (7.6% growth, 58.2% margin) is real and well-documented by the simultaneous earnings catalysts cited from Yahoo Finance, making the core thesis compelling. However, the backtest evidence is dangerously thin — just 2 trades over the 24-month window with a 100% win rate that is statistically meaningless, and all walk-forward folds produced zero triggers for the baseline configuration, meaning no robust parameter setup was established. The near-zero pair correlation of -0.02 and diversification ratio of 1.43 are mathematically elegant, but IBM's 32.4% return on equity (89th percentile), $12.1B in free cash flow, and 73.7% EPS growth make the short leg a far more aggressive bet than the idea framing suggests. Most critically, NOW's ADX sits at 3.0 against a required threshold of 20, confirming there is no actionable trend today — this setup is correctly waiting for entry conditions, not ready to trade. Until trend strength materializes and the trigger fires, the thesis is a thesis, not a trade.
**Conviction breakdown:**
- **Thesis support (72):** The fundamental divergence is strongly supported by revenue growth, margin, and balance sheet metrics, backed by concrete earnings catalysts.
- **Trade readiness (18):** ADX at 3.0 versus a 20 threshold leaves the entry far from triggering on both legs; the setup is directionless today.
- **Risk quality (55):** Tight 2.5% stop and 5.1% take-profit provide structure, but daily-bar exit fills mean the 0.94% max drawdown is a coarse approximation.
- **Backtest evidence (22):** Two trades with no walk-forward validation and a rejected parameter optimization provide almost no statistical confidence.
- **Fundamentals trend (68):** ServiceNow's improving operating leverage and R&D intensity support the long thesis, though IBM's own gradual improvement adds risk to the short.
Conviction score breakdownComposite score computed by the server from the applicable evidence-tier dimensions.
Measure
Value
Thesis support
72/100
Trade readiness
18/100
Risk quality
55/100
Backtest evidence
22/100
Fundamentals trend
68/100
Score
47/100
Composite Score
47/100
Evidence Tier
backtested
Trade now
**Current state: waiting.** The strategy wants to go long NOW and short IBM simultaneously, but neither leg's entry conditions are fully live today. On the long side, NOW closed at $110.91 with RSI (14) at 67.9 — the entry needs RSI below 65, so it's about 3 points too hot. The 9-period EMA ($105.05) is above the 21-period EMA ($103.83), which is directionally correct, but the ADX (14) sits at 3.0 against a threshold of 20, meaning there is essentially no trend strength to confirm the crossover. That ADX gap is the binding constraint: the pair idea's thesis depends on a decisive spending rotation, and a 3.0 ADX reads as anything but decisive.
On the short side, IBM closed at $226.15. Its MACD line (-13.4) is already below NOW's MACD signal (0.78), so that condition is met — IBM momentum is lagging as the thesis predicts. But the same ADX problem appears here: NOW's ADX (3.0) needs to be above 20, and it's not close. The strategy is correctly structured as a relative-value bet — the 730-day correlation between IBM and NOW is roughly -0.02, so the diversification ratio of 1.43 is real — but until trend strength arrives, there's no trigger.
**What "wait" means concretely:** Do not leg in early. The 24-month backtest produced 2 trades with a 100% win rate and a 1.52% return, but that sample is thin; the parameter sensitivity analysis rejected all alternative EMA and RSI configurations for insufficient walk-forward evidence, and no robust setup was established beyond the frozen baseline. The hard stop is at -2.53% unrealized PnL and the take-profit is at 5.06%, giving an effective reward-to-risk of roughly 2:1. Wait for NOW's ADX to break above 20 and RSI to cool below 65 — both conditions firing on the same bar as the EMA-9/EMA-21 crossover is what validates the entry.
Position sizing caps each leg at 25% of capital with a $100 minimum notional, sized off a 2.53% fixed-risk budget. If you wanted to pre-position, the nearest support on NOW is $110 and the nearest resistance is $110.84 — the stock is trading right between them, which underscores how directionless the setup currently is. Patience is the trade.
IBM price and trigger mapUses the idea timeframe and keeps price levels on the price axis.
Measure
Value
Ticker
IBM
Timeframe
1d
NOW price and trigger mapUses the idea timeframe and keeps price levels on the price axis.
Measure
Value
Ticker
NOW
Timeframe
1d
The growth and AI-monetization gap is real — and widening
The thesis hinges on a widening divergence between ServiceNow as an AI winner and IBM as an AI laggard, and the fundamentals back this up convincingly. ServiceNow grew revenue 20.9% year-over-year to $13.3B, while IBM managed just 7.6% growth on $67.5B — roughly a third of ServiceNow's pace. More tellingly, ServiceNow's gross margin of 77.5% (85th percentile in Information Technology) dwarfs IBM's 58.2% (62nd percentile), reflecting the structural advantage of a cloud-native platform versus a legacy infrastructure business. The idea's core argument that enterprise AI spending is flowing to platforms successfully monetizing it is…
NOW Free cash flowFree cash flow trend from CommonQuant fundamentals/XBRL data; +150.5% from first to latest point.
Measure
Value
2010-06-30
$-9116000
2010-12-31
$8654000
2011-06-30
$28735000
2011-06-30
$20081000
2011-09-30
$27248000
2011-12-31
$5261000
2012-03-31
$7521000
2012-06-30
$2792000
2012-09-30
$-61000
2012-12-31
$6700000
2013-03-31
$4608000
Latest Value
$4608000
Change Pct
$150.54848617814832
Ticker
NOW
Timeframe
reported periods
NOW RevenueRevenue trend from CommonQuant fundamentals/XBRL data; +98.3% from first to latest point.
Measure
Value
2010-06-30
$43329000
2010-12-31
$37944000
2011-06-30
$92641000
2011-09-30
$34197000
2011-12-31
$73375000
2012-03-31
$47431000
2012-06-30
$56774000
2012-09-30
$64345000
2012-12-31
$243712000
2013-03-31
$85939000
Latest Value
$85939000
Change Pct
$98.34060329109832
Ticker
NOW
Timeframe
reported periods
IBM sector percentile checkRanks IBM against 580 companies in its sector using CommonQuant fundamentals.